Cargando…
Topical use of tranexamic acid can reduce opioid consumption compared with intravenous use for patients undergoing primary total hip arthroplasty: a prospective randomized controlled trial
BACKGROUND: The problem of opioid addiction after total hip arthroplasty (THA) has been widely concerned. Tranexamic acid (TXA) has been shown to be effective in reducing blood loss for patients undergoing THA, but few studies focus on its alleviation of postoperative local pain symptoms. The purpos...
Autores principales: | Shen, Lei, Jiang, Zhenhuan, Wang, Qiang, Xu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239156/ https://www.ncbi.nlm.nih.gov/pubmed/37270493 http://dx.doi.org/10.1186/s12891-023-06576-7 |
Ejemplares similares
-
Combined use of intravenous and topical tranexamic acid in patients aged over 70 years old undergoing total hip arthroplasty
por: Jia, Junqing
Publicado: (2019) -
Comparison of intravenous and topical tranexamic acid in total knee arthroplasty
por: Wei, Wenbo, et al.
Publicado: (2018) -
Is combined topical and intravenous tranexamic acid superior to intravenous tranexamic acid alone for controlling blood loss after total hip arthroplasty?: A meta-analysis
por: Zhang, Hua, et al.
Publicado: (2017) -
Comparison of efficacy and safety of topical versus intravenous tranexamic acid in total hip arthroplasty: A meta-analysis
por: Li, Jian, et al.
Publicado: (2016) -
Is topical or intravenous tranexamic acid preferred in total hip arthroplasty? A randomized, controlled, noninferiority clinical trial
por: Zhou, Kai-di, et al.
Publicado: (2018)